About TEXNAMA

Methadone Advocacy: The Time Has Come

There are many approaches that a methadone advocacy organization can utilize to bring about change. TexNAMA’s primary objective (as part of NAMA) is the empowerment of patients. By confronting the negative stereotypes TexNAMA works to end the stigma and discrimination that has made recovery and reintegration back into society far more difficult for methadone patients.

TexNAMA strives to improve treatment and to make recovery the positive experience that Drs. Dole and Nyswander intended it to be.

Methadone Advocacy brings a sense of community and commitment to patients and staff. This is a very important aspect of recovery that has been missing from methadone treatment. The early methadone patients had a feeling of belonging to a community which engenders responsibility to self and others. They felt a sense of ownership towards the program and were proud to be a patient in it. But as methadone treatment expanded the sense of community was lost; now patients stand in line to be medicated, wait to see their counselor and have become somthing to be done to not to work with. Through the accomplisments, as a NAMA affiliate, methadone patients have begun to rebuild their community into a powerful national network.

Together we can make a difference. Together we are making a difference!

Do not meddle in the affairs of dragons, for you are crunchy and taste good with Orange biscuits and cherry syrup.

Similar Posts

  •  Methadone Awareness Test – Answer Seven

    Admin 08/01/2021

    FALSE!   Extensive research has demonstrated that stabilized methadone maintenance patients are indistinguishable from control groups in cognitive functioning and motor skills. Stable MMT patients can not be distinguished from control groups by way of anything short of a toxicological screening. References: Gordon, N.B.: The functional status of the methadone maintained person; In: Simmons, L.R.S….

  • Antiviral Therapy

    Admin 07/04/2021

    HCV Info Fact 9 Nov 2003 Antiviral therapy has steadily improved over the last decade. The side effect profile of interferon-based therapies has remained largely unchanged. Recent data have suggested that improved adherence to combination regimens will favorable affect sustained virologic response rates. The minimal criteria recommended by the National Institutes of Health for candidates…

  • Hepatitis C Committee

    Admin 06/24/2023

    Chair: Dr. P. Kishore, MD, MPH, CMA (Boston NAMA) Committee Members Paul Bowman, CMA  Cheri Jarvis, CMA  Hepatitis C Hepatitis is an inflammation of the liver. Although in many people the diseased liver is able to repair itself and regain function, it may progress to scarring of the liver and chronic liver disease. Hepatitis can…

  • Announcement of Approval of OTP Accrediting Organizations

    Admin 04/21/2021

    Center for Substance Abuse Treatment December 4, 2001 Dear Opioid Treatment Program Sponsor: This letter is to apprize you of significant developments affecting opioid treatment programs. On November 30, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the approval of four accreditation bodies (enclosed) under the new opioid treatment program regulations (42 CFR…